ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $326,000 | -38.1% | 6,291 | -15.0% | 0.01% | -40.0% |
| Q1 2022 | $527,000 | +3.9% | 7,399 | +9.1% | 0.01% | -23.1% |
| Q4 2021 | $507,000 | +113.9% | 6,779 | +62.6% | 0.01% | +225.0% |
| Q3 2021 | $237,000 | -37.8% | 4,169 | -51.9% | 0.00% | -42.9% |
| Q2 2021 | $381,000 | +28.3% | 8,664 | +44.1% | 0.01% | +40.0% |
| Q1 2021 | $297,000 | -61.1% | 6,012 | -64.0% | 0.01% | -78.3% |
| Q3 2020 | $764,000 | -30.5% | 16,698 | -23.8% | 0.02% | -56.6% |
| Q2 2020 | $1,100,000 | – | 21,916 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |